We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

068760:KRXCelltrion Pharm Inc Analysis

Data as of 2026-06-12 - not real-time

₩93,500.00

Latest Price

8/10Risk

Risk Level: High

Executive Summary

Celltrion Pharm Inc is trading well above its 20‑day (47,277), 50‑day (52,595) and 200‑day (58,452) simple moving averages, suggesting a strong price momentum that is not yet reflected in the broader market sentiment. However, the technical suite is mixed: the RSI sits at 33, indicating oversold conditions, while the MACD line remains below its signal line, flagging bearish momentum, and the price sits far above the calculated resistance of 54,400, hinting at a potential overextension.
Volatility is elevated at roughly 45% over the past 30 days, beta is near‑neutral at 0.98, and the historical max drawdown of –46% underscores a history of sharp corrections. Volume is trending upward, and the Fear & Greed Index reads “Extreme Greed,” which may be inflating the price. Crucially, fundamental data is unavailable, leaving valuation and earnings outlook opaque.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Bearish MACD signal despite price above SMAs
  • Oversold RSI suggesting limited upside in the near term
  • High volatility and recent volume surge

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • Lack of fundamental data prevents a clear earnings outlook
  • Potential correction from overextended price levels
  • Neutral beta and moderate sector risk

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • Pharmaceutical industry’s long‑term growth tailwinds
  • Current price may be a discount if fundamentals improve
  • Low currency risk and adequate liquidity

Key Metrics & Analysis

Technical Analysis

TrendBearish
RSI33.6
Support₩40,000.00
Resistance₩54,400.00
MA 20₩47,277.50
MA 50₩52,595.00
MA 200₩58,451.78
MACDBearish
VolumeIncreasing
Fear & Greed Index87.52

Valuation

GradeFair
TypeBlend

Risk Assessment

Beta0.98
Volatility45.14%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.